RS56634B1 - Postupci i kompozicije za lečenje simptoma povezanih sa posttraumatskim stresnim poremećajem korišćenjem ciklobenzaprina - Google Patents
Postupci i kompozicije za lečenje simptoma povezanih sa posttraumatskim stresnim poremećajem korišćenjem ciklobenzaprinaInfo
- Publication number
- RS56634B1 RS56634B1 RS20171157A RSP20171157A RS56634B1 RS 56634 B1 RS56634 B1 RS 56634B1 RS 20171157 A RS20171157 A RS 20171157A RS P20171157 A RSP20171157 A RS P20171157A RS 56634 B1 RS56634 B1 RS 56634B1
- Authority
- RS
- Serbia
- Prior art keywords
- cyclobenzaprine
- compositions
- post
- methods
- symptoms associated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/131—Amines acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28166109P | 2009-11-20 | 2009-11-20 | |
EP10831895.7A EP2501234B1 (en) | 2009-11-20 | 2010-11-16 | Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine |
PCT/US2010/002979 WO2011062614A1 (en) | 2009-11-20 | 2010-11-16 | Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine |
Publications (1)
Publication Number | Publication Date |
---|---|
RS56634B1 true RS56634B1 (sr) | 2018-03-30 |
Family
ID=44059887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20171157A RS56634B1 (sr) | 2009-11-20 | 2010-11-16 | Postupci i kompozicije za lečenje simptoma povezanih sa posttraumatskim stresnim poremećajem korišćenjem ciklobenzaprina |
Country Status (14)
Country | Link |
---|---|
US (2) | US9918948B2 (sr) |
EP (1) | EP2501234B1 (sr) |
CY (1) | CY1119698T1 (sr) |
DK (1) | DK2501234T3 (sr) |
ES (1) | ES2649022T3 (sr) |
HR (1) | HRP20171739T1 (sr) |
HU (1) | HUE037281T2 (sr) |
LT (1) | LT2501234T (sr) |
NO (1) | NO2501234T3 (sr) |
PL (1) | PL2501234T3 (sr) |
PT (1) | PT2501234T (sr) |
RS (1) | RS56634B1 (sr) |
SI (1) | SI2501234T1 (sr) |
WO (1) | WO2011062614A1 (sr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT2501234T (lt) | 2009-11-20 | 2017-12-11 | Tonix Pharma Holdings Limited | Būdai ir kompozicijos, skirti simptomų, susijusių su potrauminiu streso sutrikimu, gydymui naudojant ciklobenzapriną |
US20110319389A1 (en) | 2010-06-24 | 2011-12-29 | Tonix Pharmaceuticals, Inc. | Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine |
AU2013274003B2 (en) * | 2012-06-15 | 2018-07-05 | Tonix Pharma Holdings Limited | Compositions and methods for transmucosal absorption |
SG10201707528WA (en) | 2013-03-15 | 2017-10-30 | Tonix Pharmaceuticals Inc | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride |
RS63583B1 (sr) | 2014-01-10 | 2022-10-31 | Bioverativ Therapeutics Inc | Himerni proteini faktora viii i njihova upotreba |
SG11201701995PA (en) | 2014-09-18 | 2017-04-27 | Tonix Pharma Holdings Ltd | Eutectic formulations of cyclobenzaprine hydrochloride |
EP3723860A1 (en) | 2017-12-11 | 2020-10-21 | Tonix Pharma Holdings Limited | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions |
CN113194935A (zh) * | 2018-08-20 | 2021-07-30 | 通尼克斯制药控股有限公司 | 治疗急性应激障碍和创伤后应激障碍的方法 |
EP3883546A1 (en) | 2018-11-21 | 2021-09-29 | Rosemont Pharmaceuticals Ltd | Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability |
JP7088153B2 (ja) * | 2019-09-19 | 2022-06-21 | カシオ計算機株式会社 | Cap(周期性脳波活動)検出装置、cap(周期性脳波活動)検出方法及びプログラム |
CN115803088A (zh) * | 2020-04-08 | 2023-03-14 | 通尼克斯医药控股公司 | 性功能障碍的环苯扎林治疗 |
CN116887830A (zh) | 2020-11-20 | 2023-10-13 | 通尼克斯医药控股公司 | 酒精使用障碍的环苯扎林治疗 |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4968507A (en) | 1984-06-20 | 1990-11-06 | Merck & Co., Inc. | Controlled porosity osmotic pump |
US5073543A (en) * | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
US5120548A (en) * | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5733566A (en) * | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
SG47101A1 (en) * | 1992-07-31 | 1998-03-20 | Us Bioscience | Crystalline amifostine compositions and methods for the preparation and use of same |
US5591767A (en) * | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
US6096331A (en) * | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
DK0693924T4 (da) * | 1993-02-22 | 2008-08-04 | Abraxis Bioscience Inc | Fremgangsmåde til (in vivo) levering af biologiske materialer og sammensætninger, der er egnede dertil |
US6753006B1 (en) * | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
US5439686A (en) * | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
US6749868B1 (en) * | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
US6537579B1 (en) * | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
IT1270594B (it) * | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
US5834025A (en) * | 1995-09-29 | 1998-11-10 | Nanosystems L.L.C. | Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
US20030077227A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
WO1999018937A1 (en) | 1997-10-16 | 1999-04-22 | Merck & Co., Inc. | New cyclobenzaprine composition |
AU3885799A (en) | 1998-05-14 | 1999-11-29 | Alza Corporation | Antidepressant therapy |
US7374779B2 (en) | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6761903B2 (en) * | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
US6309663B1 (en) * | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
JP2003506483A (ja) * | 1999-08-13 | 2003-02-18 | ベラ・ファーマシューティカルズ・インコーポレイテッド | シクロベンザプリンおよびその組成物による全般性不安障害の処置 |
DE60021266T2 (de) | 1999-08-13 | 2006-05-24 | L&L Technologies, Llc | Verwendungen von Zusammensetzungen zur Behandlung oder Vorbeugung von Schlafstörungen unter Verwendung von sehr niedrigen Dosen von Cyclobenzaprin |
US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
AU2001261744A1 (en) | 2000-05-19 | 2001-12-03 | Npd Llc | Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements |
US20030087814A1 (en) * | 2001-11-05 | 2003-05-08 | Seth Lederman | Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
US7700561B2 (en) * | 2002-02-22 | 2010-04-20 | Shire Llc | Abuse-resistant amphetamine prodrugs |
US7659253B2 (en) * | 2002-02-22 | 2010-02-09 | Shire Llc | Abuse-resistant amphetamine prodrugs |
US7105486B2 (en) * | 2002-02-22 | 2006-09-12 | New River Pharmaceuticals Inc. | Abuse-resistant amphetamine compounds |
AU2003284342B2 (en) * | 2002-10-25 | 2009-03-05 | Collegium Pharmaceutical, Inc. | Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof |
DK1585548T3 (en) * | 2002-12-09 | 2018-09-03 | Abraxis Bioscience Llc | COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS |
KR101170840B1 (ko) * | 2003-05-29 | 2012-08-03 | 샤이어 엘엘씨 | 남용 방지성 암페타민 화합물 |
BRPI0415683A (pt) * | 2003-11-03 | 2006-12-19 | Warner Lambert Co | inibidores da reabsorção de norepinefrina para o tratamento de distúrbios do sistema nervoso central |
US20050143350A1 (en) | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
JP2007516259A (ja) | 2003-12-09 | 2007-06-21 | メッドクリスタルフォームズ、エルエルシー | 活性剤との混合相共結晶の調製方法 |
EP1715853A4 (en) * | 2004-02-17 | 2012-07-18 | Transcept Pharmaceuticals Inc | COMPOSITIONS FOR THE DISTRIBUTION OF HYPNOTICS IN THE FIELD OF MUNICHCHLEIMHÄUTE AND USE METHOD THEREOF |
US8216610B2 (en) | 2004-05-28 | 2012-07-10 | Imaginot Pty Ltd. | Oral paracetamol formulations |
US7532935B2 (en) * | 2005-07-29 | 2009-05-12 | Cyberonics, Inc. | Selective neurostimulation for treating mood disorders |
US7994220B2 (en) | 2005-09-28 | 2011-08-09 | Cypress Bioscience, Inc. | Milnacipran for the long-term treatment of fibromyalgia syndrome |
US20090069267A1 (en) * | 2006-01-17 | 2009-03-12 | Abrams Daniel J | Central administration of stable formulations of therapeutic agents for cns conditions |
US20080146672A1 (en) | 2006-12-08 | 2008-06-19 | Denton Marcia Marye | Topical Eutectic Anesthetic Composition for Oral or Dermal Tissue |
WO2009002770A1 (en) * | 2007-06-22 | 2008-12-31 | Merck & Co., Inc. | 6.5-pyrrolopiperidine tachykinin receptor antagonists |
CN101951912A (zh) * | 2007-07-23 | 2011-01-19 | 辛诺西亚治疗公司 | 创伤后应激障碍的治疗 |
US20090060983A1 (en) | 2007-08-30 | 2009-03-05 | Bunick Frank J | Method And Composition For Making An Orally Disintegrating Dosage Form |
AU2008303129B2 (en) | 2007-09-25 | 2013-08-01 | Formulex Pharma Innovations Ltd. | Compositions comprising lipophilic active compounds and method for their preparation |
EP2203158A4 (en) | 2007-10-30 | 2012-12-26 | Reddys Lab Ltd Dr | PHARMACEUTICAL FORMULATIONS WITH TELMISARTAN AND HYDROCHLORTHIAZIDE |
US20090148532A1 (en) * | 2007-12-06 | 2009-06-11 | Venkatesh Gopi M | Preparation of controlled release skeletal muscle relaxant dosage forms |
EP2240022B1 (en) | 2008-01-09 | 2016-12-28 | Charleston Laboratories, Inc. | Bilayered tablets comprising oxycodone and promethazine |
US9314469B2 (en) * | 2008-05-05 | 2016-04-19 | Tonix Pharma Holdings Limited | Method for treating neurocognitive dysfunction |
US20100266682A1 (en) * | 2008-12-10 | 2010-10-21 | Nipun Davar | Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same |
US20100247586A1 (en) | 2009-03-27 | 2010-09-30 | Andreas Hugerth | Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties |
EP2233134A1 (en) | 2009-03-27 | 2010-09-29 | McNeil AB | Multi-portion intra-oral dosage form with organoleptic properties |
US8784781B2 (en) | 2009-09-24 | 2014-07-22 | Mcneil-Ppc, Inc. | Manufacture of chewing gum product with radiofrequency |
LT2501234T (lt) | 2009-11-20 | 2017-12-11 | Tonix Pharma Holdings Limited | Būdai ir kompozicijos, skirti simptomų, susijusių su potrauminiu streso sutrikimu, gydymui naudojant ciklobenzapriną |
US20110319389A1 (en) * | 2010-06-24 | 2011-12-29 | Tonix Pharmaceuticals, Inc. | Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine |
JP6355921B2 (ja) * | 2010-09-01 | 2018-07-11 | トニックス ファーマスーティカルズ, インコーポレイテッドTONIX Pharmaceuticals, Inc. | コカイン嗜癖の治療 |
US20120232159A1 (en) * | 2011-03-07 | 2012-09-13 | Tonix Pharmaceuticals, Inc. | Methods and Compositions for Treating Depression using Cyclobenzaprine |
AU2013274003B2 (en) | 2012-06-15 | 2018-07-05 | Tonix Pharma Holdings Limited | Compositions and methods for transmucosal absorption |
SG10201707528WA (en) | 2013-03-15 | 2017-10-30 | Tonix Pharmaceuticals Inc | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride |
SG11201701995PA (en) | 2014-09-18 | 2017-04-27 | Tonix Pharma Holdings Ltd | Eutectic formulations of cyclobenzaprine hydrochloride |
-
2010
- 2010-11-16 LT LTEP10831895.7T patent/LT2501234T/lt unknown
- 2010-11-16 SI SI201031573T patent/SI2501234T1/en unknown
- 2010-11-16 DK DK10831895.7T patent/DK2501234T3/en active
- 2010-11-16 RS RS20171157A patent/RS56634B1/sr unknown
- 2010-11-16 HU HUE10831895A patent/HUE037281T2/hu unknown
- 2010-11-16 WO PCT/US2010/002979 patent/WO2011062614A1/en active Application Filing
- 2010-11-16 PT PT108318957T patent/PT2501234T/pt unknown
- 2010-11-16 PL PL10831895T patent/PL2501234T3/pl unknown
- 2010-11-16 NO NO10831895A patent/NO2501234T3/no unknown
- 2010-11-16 ES ES10831895.7T patent/ES2649022T3/es active Active
- 2010-11-16 EP EP10831895.7A patent/EP2501234B1/en active Active
- 2010-11-18 US US12/948,828 patent/US9918948B2/en active Active
-
2017
- 2017-11-13 HR HRP20171739TT patent/HRP20171739T1/hr unknown
- 2017-11-14 CY CY20171101187T patent/CY1119698T1/el unknown
-
2018
- 2018-03-08 US US15/915,688 patent/US20180193288A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SI2501234T1 (en) | 2018-02-28 |
EP2501234A4 (en) | 2013-04-24 |
US9918948B2 (en) | 2018-03-20 |
ES2649022T3 (es) | 2018-01-09 |
HRP20171739T1 (hr) | 2018-03-09 |
CY1119698T1 (el) | 2018-04-04 |
HUE037281T2 (hu) | 2018-08-28 |
PL2501234T3 (pl) | 2018-01-31 |
PT2501234T (pt) | 2017-12-13 |
US20110124656A1 (en) | 2011-05-26 |
WO2011062614A1 (en) | 2011-05-26 |
EP2501234A1 (en) | 2012-09-26 |
US20180193288A1 (en) | 2018-07-12 |
DK2501234T3 (en) | 2017-12-04 |
EP2501234B1 (en) | 2017-09-13 |
NO2501234T3 (sr) | 2018-02-10 |
LT2501234T (lt) | 2017-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2501234T (pt) | Métodos e composições para o tratamento de sintomas associados com distúrbios de stress pós-traumático utilizando ciclobenzaprina | |
IL262668A (en) | Preparations for the treatment of Gaucher disease | |
IL284067B (en) | Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases | |
HK1174064A1 (zh) | 用於細胞增殖相關的疾病的方法和組合物 | |
EP2406389A4 (en) | METHOD AND COMPOSITIONS FOR CELL-RETENTION-BASED DISEASES | |
IL228030A0 (en) | Methods and compositions for the treatment of gout and gout-related metabolic disorders | |
EP2504428A4 (en) | METHOD AND COMPOSITIONS FOR TREATING OXALATE-MEDIATED SUFFERING | |
IL215932A0 (en) | Compositions and methods for treating burns | |
EP2429584A4 (en) | TREATMENT PROCEDURE AND COMPOSITIONS | |
ZA201203002B (en) | Compositions and methods for treating inflammatory disorders | |
BR112012006437A2 (pt) | composições e métodos para tratamento do diabetes e outros distúrbios | |
RS60240B1 (sr) | Postupci i kompozicije za lečenje depresije korišćenjem ciklobenzaprina | |
EP2340254A4 (en) | COMPOSITIONS AND METHODS FOR TREATING EPILEPSY | |
IL214757A0 (en) | Compositions and methods to prevent and/or treat cancer with pa-card | |
EP2643470A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF ILLNESSES AND SUFFERINGS RELATING TO D-DT | |
GB201009037D0 (en) | Compositions and methods for treating disorders associated with atherosclerotic plaques | |
IL226390B (en) | Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases |